Time Commitment: 2 Hrs 30 min over 60 days
Group Size: 12 Maximum Group Members
Credits Available: 1.0 AMA PRA Category 1 Credit(s)™: 1.0 contact hour of continuing pharmacy education credit; 1.0 contact hour for nurses

The overall goal of this CE initiative is to establish meaningful, small group interactions between clinicians involved in the care of patients with breast cancer that will, through a variety of collaborative educational experiences, help them optimally manage HER2-positive breast cancer patients who have received prior anti-HER2 targeted therapies.

Self Study

Live Group Discussions

  • Live Web Meeting 1

    This live meeting will consist of a Group Leader-led discussion on best practices related to treatment selection, monitoring and managing treatment related adverse events, and adherence challenges in patients with HER2-positive metastatic breast cancer.

  • Live Web Meeting 2

    This live meeting will consist of a Group Leader-led discussion to review key points from the group task and address group member questions and/or low scoring items on the baseline assessment.

Group Tasks

  • “Making Sense of the Evolving Standards of Care for Advanced HER2+ Breast Cancer”

    This group task involves the presentation of an authentic case scenario of an HER2+ metastatic breast cancer patient. Each participant will be assigned to describe one aspect of the comprehensive management of the case.

Interested in becoming a Group Leader?

Group Leaders are physicians, advanced practice providers (NP/PA), or oncology pharmacists with experience caring for patients diagnosed with HER2+ breast cancer. Apply Now

You cannot sign up as a Group Member because there are no groups available or because you are already signed up.